Page 30 - Sohini Das

Imports of medical devices rise 21% till October to Rs 61,262.84 cr

Imports from the US grew by 33 per cent, followed by Germany (27 per cent) and the Netherlands (20 per cent). The imports from China grew by 11 per cent the data shows

ICMR invites suggestions for revising national essential diagnostics list

It is unclear whether the finalisation of the NEDL will lead to price capping of diagnostic tests in line with drugs

Fortis Healthcare plans acquisitions, may opt for neutral brand name

We have taken a calculative view that at least for SRL, we have moved to the Agilus brand, and we have successfully completed that last year, said CFO of Fortis Healthcare

Bombay High Court junks pleas challenging closure of Talegaon plant

The High Court upheld the decision of the Industrial Tribunal allowing GMI to close the plant after noting accumulated losses of Rs 9,656.87 crore as of 2021-22

Price push: Domestic pharma market grew by 6.8% in 2023, shows data

Cardiology, anti-infectives, and gastro-intestinal therapies were in the top three - growing 6.3 per cent, 8 per cent, and 5.2 per cent, respectively, in value term

Going viral: How is the pharma market coping with Janaushadhi Kendras?

Janaushadhi Kendras sell generic drugs that are priced 50 to 60 per cent lower than the popular brands

Honda expands capacity to 1.97 mn units in scooter-only plant in Gujarat

Prior to this expansion, the plant had a capacity to produce 1.3 million units a year of scooter models like the Activa, Dio, Activa 125, Dio 125, etc

Passenger vehicles in fast lane: 2024 begins with 75% surge in inventory

2023 saw 11% growth in automobile retail sales, setting the momentum for the year ahead

Bajaj Auto board approves Rs 4,000 cr share buyback at Rs 10,000 apiece

The company will be buying 4 million shares via the tender route, representing 1.41 per cent of Bajaj Auto's outstanding shares

Investor perception about Aster DM Healthcare is 'very upbeat': CEO

Group will avoid being 'one of those players' with a token presence through a single hospital, says Nitish Shetty

Bajaj Auto board to consider share buyback on Jan 8, stock jumps over 5%

Under the Securities and Exchange Board of India (Sebi) regulations, the maximum limit for a buyback is 25 per cent or less of the paid-up capital and free reserves in that financial year

India launches a single-window portal for medical devices management

The Drugs Controller General of India said that the National Single Window System (NSWS) has been established as a 'genuine single-window system which acts as a one-stop shop for all approvals'

From Ashok Leyland to VECV, busmakers' sales entered the fast lane in 2023

Ashok Leyland Limited (ALL) recorded a 64 per cent year-on-year increase in sales of medium and heavy commercial vehicle (MHCV) buses during the April-to-December period of 2023 to 11,216 units

PV sales surge past 4 mn, fueled by SUV demand, record December wholesales

Interest rate hikes, high base of 2023 may result in muted volume growth in 2024

Consumers moved away from diesel vehicles in 2023; EV, hybrid sales rise

SUVs, on the other hand, are likely to grow up to 54-55 per cent from a current level of 48.7 per cent. It has already grown from 42 per cent in 2022 to nearly 49 per cent in 2023

Corporates relook at work-from-home policy as Covid cases resurge

India reports a single-day spike of 702 cases; 6 deaths

Few shares of Keshub, Sudha Mahindra in PMSL transferred to family members

The transmission disclosed herein involves a change in the shareholding/voting rights of PMSL as a result of the transmission of certain shares of PMSL, and does not pertain to shares of M&M directly

Biological E develops next gen XBB1.5 variant Covid vax, awaits clearance

XBB 1.5 is a sub-variant of Omicron, and a sub-linear of XBB variant. It is a recombinant of the two BA.2 sublineages, and carries a mutation of the spike protein (F486P)

Covid-19 back this winter but vaccine makers have limited stockpiles

Gennova has 1 mn doses of Omicron-specific vax; Serum's Covovax available at vaccination centres, shows CoWIN

Trade generics growth to dent value expansion of domestic drug market

Jan Aushadhi and trade generics together constitute 20-22% of pharma market volumes